Published in Eur J Nucl Med Mol Imaging on February 06, 2010
Hybrid versus fusion imaging: are we moving forward judiciously? Eur J Nucl Med Mol Imaging (2010) 1.39
Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem Soc Rev (2011) 1.36
The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond. Insights Imaging (2011) 1.13
PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol (2013) 0.99
Competitive advantage of PET/MRI. Eur J Radiol (2013) 0.98
PET/MR: a paradigm shift. Cancer Imaging (2013) 0.90
Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging. Eur J Nucl Med Mol Imaging (2012) 0.88
Discrimination and anatomical mapping of PET-positive lesions: comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen. Eur J Nucl Med Mol Imaging (2012) 0.84
MR/PET or PET/MRI: does it matter? MAGMA (2013) 0.77
Workflow Lexicons in Healthcare: Validation of the SWIM Lexicon. J Digit Imaging (2017) 0.75
Hybrid versus fusion imaging: some points of clarification. Eur J Nucl Med Mol Imaging (2010) 0.75
Attenuation correction for a combined 3D PET/CT scanner. Med Phys (1998) 3.72
Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology (2008) 2.65
PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet. Radiology (2007) 2.36
Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging (2009) 2.28
Dual-modality imaging: combining anatomy and function. J Nucl Med (2008) 1.72
Cardiac image fusion from stand-alone SPECT and CT: clinical experience. J Nucl Med (2007) 1.60
PET/MRI system design. Eur J Nucl Med Mol Imaging (2009) 1.39
Multimodality image registration with software: state-of-the-art. Eur J Nucl Med Mol Imaging (2009) 1.22
A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging (2009) 1.01
The role of hybrid SPECT-CT in oncology: current and emerging clinical applications. Clin Radiol (2008) 0.97
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys (2003) 2.10
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy. J Nucl Med (2004) 1.74
Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J Nucl Med (2005) 1.69
Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning. Radiother Oncol (2006) 1.67
Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys (2005) 1.52
Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy. Eur J Nucl Med Mol Imaging (2015) 1.41
Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol (2002) 1.41
PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging (2002) 1.38
The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med (2002) 1.35
Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab (2002) 1.34
PET/MR imaging of bone lesions--implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging (2012) 1.34
Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. Am J Psychiatry (2011) 1.34
Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology (2003) 1.22
Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology (2003) 1.16
CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging (2002) 1.13
CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med (2004) 1.12
Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases. Radiology (2002) 1.11
Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med (2002) 1.07
Fusion of positron emission tomography (PET) and gene array data: a new approach for the correlative analysis of molecular biological and clinical data. IEEE Trans Med Imaging (2007) 1.06
Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water. Eur J Nucl Med Mol Imaging (2012) 1.05
PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol (2002) 0.99
Comparison of PET template-based and MRI-based image processing in the quantitative analysis of C11-raclopride PET. EJNMMI Res (2014) 0.98
Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J Nucl Med (2003) 0.98
Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol (2007) 0.97
Semiconductor detectors allow low-dose-low-dose 1-day SPECT myocardial perfusion imaging. J Nucl Med (2011) 0.96
A femoral arteriovenous shunt facilitates arterial whole blood sampling in animals. Eur J Nucl Med Mol Imaging (2002) 0.96
Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med (2003) 0.95
Quantification of cerebral blood flow in nonhuman primates using arterial spin labeling and a two-compartment model. Magn Reson Imaging (2007) 0.93
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography. Proc Natl Acad Sci U S A (2012) 0.92
Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging (2006) 0.92
[18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 0.90
Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator. Neuroimage (2007) 0.90
Absolute quantification of myocardial blood flow with 13N-ammonia and 3-dimensional PET. J Nucl Med (2007) 0.90
Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUVmax. Nucl Med Biol (2012) 0.88
Quantitative cerebral blood flow measurements in the rat using a beta-probe and H2 15O. J Cereb Blood Flow Metab (2003) 0.83
Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography. Neuroimage (2011) 0.83
Simplified quantification of FDG metabolism in tumors using the autoradiographic method is less dependent on the acquisition time than SUV. Nucl Med Biol (2011) 0.80
Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate. Eur J Nucl Med Mol Imaging (2003) 0.79
A beta-scintillator for surface measurements of radiotracer kinetics in the intact rodent cortex. Neuroimage (2009) 0.78
Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: validation of a new fast factor analysis. J Nucl Cardiol (2007) 0.77
Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system. Nucl Med Commun (2007) 0.76
Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status. J Nucl Med (2004) 0.76
PET imaging of dopamine transporters in the human brain using [(11)C]-beta-CPPIT, a cocaine derivative lacking the 2 beta-ester function. Nucl Med Biol (2002) 0.75